GENOGenovis ABGENO info
$2.32info-4.40%24h
Global rank18993
Market cap$151.91M
Change 7d-10.49%
YTD Performance-54.04%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Genovis AB (GENO) Stock Overview

    Genovis AB (publ.) designs, develops, and sells tools for development of new treatment methods and diagnostics for customers in the pharmaceutical and medical device industries. The company offers FabALACTICA, a cysteine protease that digests human IgG1; FabRICATOR, an enzyme that digests the hinge region of IgG; and FabRICATOR Z, an enzyme for the digestion of mouse IgG2a and IgG3, and generating a homogenous pool of F(ab')2 and Fc fragments. It also provides FabULOUS (SpeB), an enzyme for the digestion of IgG in the hinge region; GingisKHAN, a cysteine protease that digests human IgG1; and FabDELLO, a protease that digests human IgG1. In addition, the company offers GingisREX, a cysteine protease that specifically digests peptide bonds C-terminally; GlySERIAS, an enzyme that digests flexible glycine-rich fusion protein linkers; GlyCLICK, a conjugation technology for site-specific and quantitative conjugation of IgG; TransGLYCIT, a platform technology that enables site-specific human IgG glycan remodeling; OmniGLYZOR, a mixture of immobilized enzymes; PNGase F, a glycoamidase hydrolyzing the amide bond between the polypeptide asparagine and the innermost GlcNAc; and OpeRATOR, an O-glycan-specific protease. Further, it provides OglyZOR, an endoglycosidase; SialEXO, a sialidase product; FucosEXO, a mix of a-Fucosidases; GalactEXO, a ß-Galactosidase mix; GalNAcEXO, an a-N-Acetylgalactosaminidase; GlycOCATCH, an affinity resin for purification of mucin-type O-glycosylated proteins and peptides; GlycINATOR (EndoS2), an IgG-specific endoglycosidase; IgGZERO (EndoS), an IgG-specific endoglycosidase; Anti-FabRICATOR (Anti-IdeS), a goat polyclonal antibody; and Anti-FabRICATOR Z (Anti-IdeZ), a goat polyclonal antibody, as well as operates online store for its products. It serves pharmaceutical and biotech, contract research, and contract manufacturing companies in Sweden, Europe, North America, and Asia. Genovis AB (publ.) was founded in 1999 and is based in Lund, Sweden.

    GENO Stock Information

    Symbol
    GENO
    Address
    Scheelevägen 2Lund, 220 07Sweden
    Founded
    -
    Trading hours
    -
    Website
    https://www.genovis.com
    Country
    🇸🇪 Sweden
    Phone Number
    46 46 10 12 30

    Genovis AB (GENO) Price Chart

    -
    Value:-

    Genovis AB Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.32
    N/A
    Market Cap
    $151.91M
    N/A
    Shares Outstanding
    65.47M
    N/A
    Employees
    37.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org